J PHARM SCI-US 润色咨询

JOURNAL OF PHARMACEUTICAL SCIENCES

出版年份:1961 年文章数:7328 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:10.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1093920, encodeId=9ce7109392011, content=模式图一般放在讨论中展示还是放在结果部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093919, encodeId=fd3710939195c, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084682, encodeId=f735108468250, content=想问下这个杂志是只能通讯作者邮箱收到返修等邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d5b5506820, createdName=ms1000001844772998, createdTime=Mon Dec 27 15:03:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533091, encodeId=3ac5533091ce, content=麻烦问一下,一审大约需要多久啊?接收率高不高啊?好投不?谢谢您了<span class="quote">野比大雄 2016-02-24 发表::<br>研究方向:细胞吸收;; 求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。</span>, beContent=野比大雄 2016-02-24 发表:: 研究方向:细胞吸收;; 求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d90f1703669, createdName=幸always福, createdTime=Mon Feb 20 13:07:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833316, encodeId=9b3a833316d9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:这个杂志的eab成员和科学顾问哪些是细胞吸收或重要研究方向的?<br> 杂志推荐审稿人好像必须要有eab成员和科学顾问。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Mon Aug 22 22:29:30 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519453, encodeId=9fde5194530b, content=求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Wed Feb 24 10:31:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827427, encodeId=9c8482e42725, content=编辑受理很快 一天之内就能发出去给审稿人 很不错 后续期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Aug 13 21:03:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824521, encodeId=6ea98245214d, content=2个审稿人,1审一个月,提出的意见建议均不错,审稿人十分熟悉该领域;认真修改一个月,全部正面回应审稿意见,返回,40天后直接接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7c35414048, createdName=ms6216037977688050, createdTime=Sat Mar 16 09:38:00 CST 2013, time=2013-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817677, encodeId=93df81e67783, content=正在投这个杂志,请问这个要求选2个审稿人的editorial advisory board网上在哪能找到呢?没有杂志的纸质版,谢谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Mon Jan 09 23:04:00 CST 2012, time=2012-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816822, encodeId=93cb81682213, content=想问下 这个杂志要求的保证书 在哪里可以找到呢?主编要我发一个*证书*去 还有就是要求我至少两个审稿人是编辑咨询委员会的成员 这个怎么处理呢?<br> 非常感谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Mon Nov 07 11:31:00 CST 2011, time=2011-11-07, status=1, ipAttribution=)]
    2021-12-29 Gym璨烨

    模式图一般放在讨论中展示还是放在结果部分?

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1093920, encodeId=9ce7109392011, content=模式图一般放在讨论中展示还是放在结果部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093919, encodeId=fd3710939195c, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084682, encodeId=f735108468250, content=想问下这个杂志是只能通讯作者邮箱收到返修等邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d5b5506820, createdName=ms1000001844772998, createdTime=Mon Dec 27 15:03:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533091, encodeId=3ac5533091ce, content=麻烦问一下,一审大约需要多久啊?接收率高不高啊?好投不?谢谢您了<span class="quote">野比大雄 2016-02-24 发表::<br>研究方向:细胞吸收;; 求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。</span>, beContent=野比大雄 2016-02-24 发表:: 研究方向:细胞吸收;; 求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d90f1703669, createdName=幸always福, createdTime=Mon Feb 20 13:07:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833316, encodeId=9b3a833316d9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:这个杂志的eab成员和科学顾问哪些是细胞吸收或重要研究方向的?<br> 杂志推荐审稿人好像必须要有eab成员和科学顾问。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Mon Aug 22 22:29:30 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519453, encodeId=9fde5194530b, content=求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Wed Feb 24 10:31:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827427, encodeId=9c8482e42725, content=编辑受理很快 一天之内就能发出去给审稿人 很不错 后续期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Aug 13 21:03:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824521, encodeId=6ea98245214d, content=2个审稿人,1审一个月,提出的意见建议均不错,审稿人十分熟悉该领域;认真修改一个月,全部正面回应审稿意见,返回,40天后直接接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7c35414048, createdName=ms6216037977688050, createdTime=Sat Mar 16 09:38:00 CST 2013, time=2013-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817677, encodeId=93df81e67783, content=正在投这个杂志,请问这个要求选2个审稿人的editorial advisory board网上在哪能找到呢?没有杂志的纸质版,谢谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Mon Jan 09 23:04:00 CST 2012, time=2012-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816822, encodeId=93cb81682213, content=想问下 这个杂志要求的保证书 在哪里可以找到呢?主编要我发一个*证书*去 还有就是要求我至少两个审稿人是编辑咨询委员会的成员 这个怎么处理呢?<br> 非常感谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Mon Nov 07 11:31:00 CST 2011, time=2011-11-07, status=1, ipAttribution=)]
    2021-12-27 MS68862005

    讨论中第一段一定要撰写文章的总括么?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1093920, encodeId=9ce7109392011, content=模式图一般放在讨论中展示还是放在结果部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093919, encodeId=fd3710939195c, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084682, encodeId=f735108468250, content=想问下这个杂志是只能通讯作者邮箱收到返修等邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d5b5506820, createdName=ms1000001844772998, createdTime=Mon Dec 27 15:03:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533091, encodeId=3ac5533091ce, content=麻烦问一下,一审大约需要多久啊?接收率高不高啊?好投不?谢谢您了<span class="quote">野比大雄 2016-02-24 发表::<br>研究方向:细胞吸收;; 求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。</span>, beContent=野比大雄 2016-02-24 发表:: 研究方向:细胞吸收;; 求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d90f1703669, createdName=幸always福, createdTime=Mon Feb 20 13:07:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833316, encodeId=9b3a833316d9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:这个杂志的eab成员和科学顾问哪些是细胞吸收或重要研究方向的?<br> 杂志推荐审稿人好像必须要有eab成员和科学顾问。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Mon Aug 22 22:29:30 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519453, encodeId=9fde5194530b, content=求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Wed Feb 24 10:31:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827427, encodeId=9c8482e42725, content=编辑受理很快 一天之内就能发出去给审稿人 很不错 后续期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Aug 13 21:03:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824521, encodeId=6ea98245214d, content=2个审稿人,1审一个月,提出的意见建议均不错,审稿人十分熟悉该领域;认真修改一个月,全部正面回应审稿意见,返回,40天后直接接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7c35414048, createdName=ms6216037977688050, createdTime=Sat Mar 16 09:38:00 CST 2013, time=2013-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817677, encodeId=93df81e67783, content=正在投这个杂志,请问这个要求选2个审稿人的editorial advisory board网上在哪能找到呢?没有杂志的纸质版,谢谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Mon Jan 09 23:04:00 CST 2012, time=2012-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816822, encodeId=93cb81682213, content=想问下 这个杂志要求的保证书 在哪里可以找到呢?主编要我发一个*证书*去 还有就是要求我至少两个审稿人是编辑咨询委员会的成员 这个怎么处理呢?<br> 非常感谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Mon Nov 07 11:31:00 CST 2011, time=2011-11-07, status=1, ipAttribution=)]
    2021-12-27 ms1000001844772998

    想问下这个杂志是只能通讯作者邮箱收到返修等邮件吗?

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1093920, encodeId=9ce7109392011, content=模式图一般放在讨论中展示还是放在结果部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093919, encodeId=fd3710939195c, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084682, encodeId=f735108468250, content=想问下这个杂志是只能通讯作者邮箱收到返修等邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d5b5506820, createdName=ms1000001844772998, createdTime=Mon Dec 27 15:03:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533091, encodeId=3ac5533091ce, content=麻烦问一下,一审大约需要多久啊?接收率高不高啊?好投不?谢谢您了<span class="quote">野比大雄 2016-02-24 发表::<br>研究方向:细胞吸收;; 求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。</span>, beContent=野比大雄 2016-02-24 发表:: 研究方向:细胞吸收;; 求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d90f1703669, createdName=幸always福, createdTime=Mon Feb 20 13:07:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833316, encodeId=9b3a833316d9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:这个杂志的eab成员和科学顾问哪些是细胞吸收或重要研究方向的?<br> 杂志推荐审稿人好像必须要有eab成员和科学顾问。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Mon Aug 22 22:29:30 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519453, encodeId=9fde5194530b, content=求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Wed Feb 24 10:31:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827427, encodeId=9c8482e42725, content=编辑受理很快 一天之内就能发出去给审稿人 很不错 后续期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Aug 13 21:03:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824521, encodeId=6ea98245214d, content=2个审稿人,1审一个月,提出的意见建议均不错,审稿人十分熟悉该领域;认真修改一个月,全部正面回应审稿意见,返回,40天后直接接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7c35414048, createdName=ms6216037977688050, createdTime=Sat Mar 16 09:38:00 CST 2013, time=2013-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817677, encodeId=93df81e67783, content=正在投这个杂志,请问这个要求选2个审稿人的editorial advisory board网上在哪能找到呢?没有杂志的纸质版,谢谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Mon Jan 09 23:04:00 CST 2012, time=2012-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816822, encodeId=93cb81682213, content=想问下 这个杂志要求的保证书 在哪里可以找到呢?主编要我发一个*证书*去 还有就是要求我至少两个审稿人是编辑咨询委员会的成员 这个怎么处理呢?<br> 非常感谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Mon Nov 07 11:31:00 CST 2011, time=2011-11-07, status=1, ipAttribution=)]
    2017-02-20 幸always福

    麻烦问一下,一审大约需要多久啊?接收率高不高啊?好投不?谢谢您了野比大雄 2016-02-24 发表::
    研究方向:细胞吸收;; 求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。

    野比大雄 2016-02-24 发表:: 研究方向:细胞吸收;; 求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1093920, encodeId=9ce7109392011, content=模式图一般放在讨论中展示还是放在结果部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093919, encodeId=fd3710939195c, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084682, encodeId=f735108468250, content=想问下这个杂志是只能通讯作者邮箱收到返修等邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d5b5506820, createdName=ms1000001844772998, createdTime=Mon Dec 27 15:03:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533091, encodeId=3ac5533091ce, content=麻烦问一下,一审大约需要多久啊?接收率高不高啊?好投不?谢谢您了<span class="quote">野比大雄 2016-02-24 发表::<br>研究方向:细胞吸收;; 求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。</span>, beContent=野比大雄 2016-02-24 发表:: 研究方向:细胞吸收;; 求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d90f1703669, createdName=幸always福, createdTime=Mon Feb 20 13:07:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833316, encodeId=9b3a833316d9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:这个杂志的eab成员和科学顾问哪些是细胞吸收或重要研究方向的?<br> 杂志推荐审稿人好像必须要有eab成员和科学顾问。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Mon Aug 22 22:29:30 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519453, encodeId=9fde5194530b, content=求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Wed Feb 24 10:31:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827427, encodeId=9c8482e42725, content=编辑受理很快 一天之内就能发出去给审稿人 很不错 后续期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Aug 13 21:03:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824521, encodeId=6ea98245214d, content=2个审稿人,1审一个月,提出的意见建议均不错,审稿人十分熟悉该领域;认真修改一个月,全部正面回应审稿意见,返回,40天后直接接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7c35414048, createdName=ms6216037977688050, createdTime=Sat Mar 16 09:38:00 CST 2013, time=2013-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817677, encodeId=93df81e67783, content=正在投这个杂志,请问这个要求选2个审稿人的editorial advisory board网上在哪能找到呢?没有杂志的纸质版,谢谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Mon Jan 09 23:04:00 CST 2012, time=2012-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816822, encodeId=93cb81682213, content=想问下 这个杂志要求的保证书 在哪里可以找到呢?主编要我发一个*证书*去 还有就是要求我至少两个审稿人是编辑咨询委员会的成员 这个怎么处理呢?<br> 非常感谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Mon Nov 07 11:31:00 CST 2011, time=2011-11-07, status=1, ipAttribution=)]
    2016-08-22 ms1700929302443684

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:这个杂志的eab成员和科学顾问哪些是细胞吸收或重要研究方向的?
    杂志推荐审稿人好像必须要有eab成员和科学顾问。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1093920, encodeId=9ce7109392011, content=模式图一般放在讨论中展示还是放在结果部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093919, encodeId=fd3710939195c, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084682, encodeId=f735108468250, content=想问下这个杂志是只能通讯作者邮箱收到返修等邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d5b5506820, createdName=ms1000001844772998, createdTime=Mon Dec 27 15:03:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533091, encodeId=3ac5533091ce, content=麻烦问一下,一审大约需要多久啊?接收率高不高啊?好投不?谢谢您了<span class="quote">野比大雄 2016-02-24 发表::<br>研究方向:细胞吸收;; 求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。</span>, beContent=野比大雄 2016-02-24 发表:: 研究方向:细胞吸收;; 求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d90f1703669, createdName=幸always福, createdTime=Mon Feb 20 13:07:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833316, encodeId=9b3a833316d9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:这个杂志的eab成员和科学顾问哪些是细胞吸收或重要研究方向的?<br> 杂志推荐审稿人好像必须要有eab成员和科学顾问。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Mon Aug 22 22:29:30 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519453, encodeId=9fde5194530b, content=求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Wed Feb 24 10:31:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827427, encodeId=9c8482e42725, content=编辑受理很快 一天之内就能发出去给审稿人 很不错 后续期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Aug 13 21:03:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824521, encodeId=6ea98245214d, content=2个审稿人,1审一个月,提出的意见建议均不错,审稿人十分熟悉该领域;认真修改一个月,全部正面回应审稿意见,返回,40天后直接接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7c35414048, createdName=ms6216037977688050, createdTime=Sat Mar 16 09:38:00 CST 2013, time=2013-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817677, encodeId=93df81e67783, content=正在投这个杂志,请问这个要求选2个审稿人的editorial advisory board网上在哪能找到呢?没有杂志的纸质版,谢谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Mon Jan 09 23:04:00 CST 2012, time=2012-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816822, encodeId=93cb81682213, content=想问下 这个杂志要求的保证书 在哪里可以找到呢?主编要我发一个*证书*去 还有就是要求我至少两个审稿人是编辑咨询委员会的成员 这个怎么处理呢?<br> 非常感谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Mon Nov 07 11:31:00 CST 2011, time=2011-11-07, status=1, ipAttribution=)]
    2016-02-24 野比大雄

    求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1093920, encodeId=9ce7109392011, content=模式图一般放在讨论中展示还是放在结果部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093919, encodeId=fd3710939195c, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084682, encodeId=f735108468250, content=想问下这个杂志是只能通讯作者邮箱收到返修等邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d5b5506820, createdName=ms1000001844772998, createdTime=Mon Dec 27 15:03:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533091, encodeId=3ac5533091ce, content=麻烦问一下,一审大约需要多久啊?接收率高不高啊?好投不?谢谢您了<span class="quote">野比大雄 2016-02-24 发表::<br>研究方向:细胞吸收;; 求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。</span>, beContent=野比大雄 2016-02-24 发表:: 研究方向:细胞吸收;; 求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d90f1703669, createdName=幸always福, createdTime=Mon Feb 20 13:07:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833316, encodeId=9b3a833316d9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:这个杂志的eab成员和科学顾问哪些是细胞吸收或重要研究方向的?<br> 杂志推荐审稿人好像必须要有eab成员和科学顾问。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Mon Aug 22 22:29:30 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519453, encodeId=9fde5194530b, content=求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Wed Feb 24 10:31:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827427, encodeId=9c8482e42725, content=编辑受理很快 一天之内就能发出去给审稿人 很不错 后续期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Aug 13 21:03:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824521, encodeId=6ea98245214d, content=2个审稿人,1审一个月,提出的意见建议均不错,审稿人十分熟悉该领域;认真修改一个月,全部正面回应审稿意见,返回,40天后直接接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7c35414048, createdName=ms6216037977688050, createdTime=Sat Mar 16 09:38:00 CST 2013, time=2013-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817677, encodeId=93df81e67783, content=正在投这个杂志,请问这个要求选2个审稿人的editorial advisory board网上在哪能找到呢?没有杂志的纸质版,谢谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Mon Jan 09 23:04:00 CST 2012, time=2012-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816822, encodeId=93cb81682213, content=想问下 这个杂志要求的保证书 在哪里可以找到呢?主编要我发一个*证书*去 还有就是要求我至少两个审稿人是编辑咨询委员会的成员 这个怎么处理呢?<br> 非常感谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Mon Nov 07 11:31:00 CST 2011, time=2011-11-07, status=1, ipAttribution=)]
    2013-08-13 ms6032332839474392

    编辑受理很快 一天之内就能发出去给审稿人 很不错 后续期待ing

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1093920, encodeId=9ce7109392011, content=模式图一般放在讨论中展示还是放在结果部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093919, encodeId=fd3710939195c, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084682, encodeId=f735108468250, content=想问下这个杂志是只能通讯作者邮箱收到返修等邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d5b5506820, createdName=ms1000001844772998, createdTime=Mon Dec 27 15:03:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533091, encodeId=3ac5533091ce, content=麻烦问一下,一审大约需要多久啊?接收率高不高啊?好投不?谢谢您了<span class="quote">野比大雄 2016-02-24 发表::<br>研究方向:细胞吸收;; 求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。</span>, beContent=野比大雄 2016-02-24 发表:: 研究方向:细胞吸收;; 求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d90f1703669, createdName=幸always福, createdTime=Mon Feb 20 13:07:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833316, encodeId=9b3a833316d9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:这个杂志的eab成员和科学顾问哪些是细胞吸收或重要研究方向的?<br> 杂志推荐审稿人好像必须要有eab成员和科学顾问。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Mon Aug 22 22:29:30 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519453, encodeId=9fde5194530b, content=求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Wed Feb 24 10:31:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827427, encodeId=9c8482e42725, content=编辑受理很快 一天之内就能发出去给审稿人 很不错 后续期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Aug 13 21:03:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824521, encodeId=6ea98245214d, content=2个审稿人,1审一个月,提出的意见建议均不错,审稿人十分熟悉该领域;认真修改一个月,全部正面回应审稿意见,返回,40天后直接接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7c35414048, createdName=ms6216037977688050, createdTime=Sat Mar 16 09:38:00 CST 2013, time=2013-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817677, encodeId=93df81e67783, content=正在投这个杂志,请问这个要求选2个审稿人的editorial advisory board网上在哪能找到呢?没有杂志的纸质版,谢谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Mon Jan 09 23:04:00 CST 2012, time=2012-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816822, encodeId=93cb81682213, content=想问下 这个杂志要求的保证书 在哪里可以找到呢?主编要我发一个*证书*去 还有就是要求我至少两个审稿人是编辑咨询委员会的成员 这个怎么处理呢?<br> 非常感谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Mon Nov 07 11:31:00 CST 2011, time=2011-11-07, status=1, ipAttribution=)]
    2013-03-16 ms6216037977688050

    2个审稿人,1审一个月,提出的意见建议均不错,审稿人十分熟悉该领域;认真修改一个月,全部正面回应审稿意见,返回,40天后直接接收。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1093920, encodeId=9ce7109392011, content=模式图一般放在讨论中展示还是放在结果部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093919, encodeId=fd3710939195c, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084682, encodeId=f735108468250, content=想问下这个杂志是只能通讯作者邮箱收到返修等邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d5b5506820, createdName=ms1000001844772998, createdTime=Mon Dec 27 15:03:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533091, encodeId=3ac5533091ce, content=麻烦问一下,一审大约需要多久啊?接收率高不高啊?好投不?谢谢您了<span class="quote">野比大雄 2016-02-24 发表::<br>研究方向:细胞吸收;; 求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。</span>, beContent=野比大雄 2016-02-24 发表:: 研究方向:细胞吸收;; 求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d90f1703669, createdName=幸always福, createdTime=Mon Feb 20 13:07:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833316, encodeId=9b3a833316d9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:这个杂志的eab成员和科学顾问哪些是细胞吸收或重要研究方向的?<br> 杂志推荐审稿人好像必须要有eab成员和科学顾问。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Mon Aug 22 22:29:30 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519453, encodeId=9fde5194530b, content=求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Wed Feb 24 10:31:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827427, encodeId=9c8482e42725, content=编辑受理很快 一天之内就能发出去给审稿人 很不错 后续期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Aug 13 21:03:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824521, encodeId=6ea98245214d, content=2个审稿人,1审一个月,提出的意见建议均不错,审稿人十分熟悉该领域;认真修改一个月,全部正面回应审稿意见,返回,40天后直接接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7c35414048, createdName=ms6216037977688050, createdTime=Sat Mar 16 09:38:00 CST 2013, time=2013-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817677, encodeId=93df81e67783, content=正在投这个杂志,请问这个要求选2个审稿人的editorial advisory board网上在哪能找到呢?没有杂志的纸质版,谢谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Mon Jan 09 23:04:00 CST 2012, time=2012-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816822, encodeId=93cb81682213, content=想问下 这个杂志要求的保证书 在哪里可以找到呢?主编要我发一个*证书*去 还有就是要求我至少两个审稿人是编辑咨询委员会的成员 这个怎么处理呢?<br> 非常感谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Mon Nov 07 11:31:00 CST 2011, time=2011-11-07, status=1, ipAttribution=)]
    2012-01-09 ms3860263520721591

    正在投这个杂志,请问这个要求选2个审稿人的editorial advisory board网上在哪能找到呢?没有杂志的纸质版,谢谢

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1093920, encodeId=9ce7109392011, content=模式图一般放在讨论中展示还是放在结果部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093919, encodeId=fd3710939195c, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084682, encodeId=f735108468250, content=想问下这个杂志是只能通讯作者邮箱收到返修等邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d5b5506820, createdName=ms1000001844772998, createdTime=Mon Dec 27 15:03:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533091, encodeId=3ac5533091ce, content=麻烦问一下,一审大约需要多久啊?接收率高不高啊?好投不?谢谢您了<span class="quote">野比大雄 2016-02-24 发表::<br>研究方向:细胞吸收;; 求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。</span>, beContent=野比大雄 2016-02-24 发表:: 研究方向:细胞吸收;; 求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d90f1703669, createdName=幸always福, createdTime=Mon Feb 20 13:07:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833316, encodeId=9b3a833316d9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:这个杂志的eab成员和科学顾问哪些是细胞吸收或重要研究方向的?<br> 杂志推荐审稿人好像必须要有eab成员和科学顾问。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Mon Aug 22 22:29:30 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519453, encodeId=9fde5194530b, content=求助一下,这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Wed Feb 24 10:31:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827427, encodeId=9c8482e42725, content=编辑受理很快 一天之内就能发出去给审稿人 很不错 后续期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Aug 13 21:03:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824521, encodeId=6ea98245214d, content=2个审稿人,1审一个月,提出的意见建议均不错,审稿人十分熟悉该领域;认真修改一个月,全部正面回应审稿意见,返回,40天后直接接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7c35414048, createdName=ms6216037977688050, createdTime=Sat Mar 16 09:38:00 CST 2013, time=2013-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817677, encodeId=93df81e67783, content=正在投这个杂志,请问这个要求选2个审稿人的editorial advisory board网上在哪能找到呢?没有杂志的纸质版,谢谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Mon Jan 09 23:04:00 CST 2012, time=2012-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816822, encodeId=93cb81682213, content=想问下 这个杂志要求的保证书 在哪里可以找到呢?主编要我发一个*证书*去 还有就是要求我至少两个审稿人是编辑咨询委员会的成员 这个怎么处理呢?<br> 非常感谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Mon Nov 07 11:31:00 CST 2011, time=2011-11-07, status=1, ipAttribution=)]
    2011-11-07 ms6336778790072332

    想问下 这个杂志要求的保证书 在哪里可以找到呢?主编要我发一个*证书*去 还有就是要求我至少两个审稿人是编辑咨询委员会的成员 这个怎么处理呢?
    非常感谢

    0

共17条页码: 1/2页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分